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The title compound, C19H22N2O3, {systematic name (1aR,4E,7aS,8E,10aS,-
10bR)-1a,5-dimethyl-8-[(pyrimidin-5-yl)methylidene]-2,3,6,7,7a,8,10a,10b-octahy-
drooxireno[20,30:9,10]cyclodeca[1,2-b]furan-9(1aH)-one} was obtained from the
reaction of parthenolide [systematic name (1aR,7aS,10aS,10bR,E)-1a,5-
dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[20,30:9,10]cyclo-
deca[1,2-b]furan-9(1aH)-one] with 5-bromopyrimidine under Heck reaction
conditions, and was identified as an E isomer. The molecule possesses ten-, five-
(lactone) and three-membered (epoxide) rings with a pyrimidine group as a
substituent. The ten-membered ring displays an approximate chair–chair
conformation, while the lactone ring shows a flattened envelope-type
conformation. The dihedral angle between the pyrimidine moiety and the
lactone ring system is 29.43 (7).
1. Chemical context
Parthenolide (PTL) is a sesquiterpene lactone known to
significantly target cancer stem cells, which are the putative
roots of all types of cancer (Gopal et al., 2007). PTL has been
isolated from several different plant species, feverfew leaf
(Tanacetum parthenium) being one of the major sources
(Awang, 1989). PTL exhibits a wide range of biological
activities, such as anti-inflammatory, anti-bacterial, anti-
fungal, and cytotoxic properties (Picman, 1986). Conse-
quently, PTL was discovered to be capable of inducing robust
apoptosis in primary acute myelogenous leukemia (AML)
cells (Guzman et al., 2007), proving to be equally effective
among all subpopulations within primary AML specimens,
including leukemia stem cells (LSCs). Gopal et al. (2007)
reported that PTL specifically depletes HDAC1 protein
without affecting other class I/II HDACs (histone deacetyl-
ases). Nasim et al. (2008) reported the anti-leukemic activity of
aminoparthenolide analogues. Han et al. (2009) reported on
bioactive derivatives of Heck products of PTL. Recently,
Penthala et al. (2014a) reported the anti-cancer activity of
PTL–Heck products. Recently we (Penthala et al., 2014b)
reported the crystal structure of 13-{4-[Z–2-cyano-2-(3,4,5-
trimethoxyphenyl)ethenyl]phenyl} parthenolide, an analog of
PTL, which was found to have the E configuration at C-13.
The interesting biological properties of PTL directed our
attention to design and synthesize additional bioactive deri-
vatives. In order to obtain detailed information on the struc-
tural conformation of the current molecule, including
assignment of the absolute configuration of the four stereo-
centres, and to establish the geometry of the exocyclic double
ISSN 2056-9890
bond, a single crystal X-ray structure determination has been
carried out.
2. Structural commentary
The title compound is shown in Fig. 1. The PTL substructure
of the molecule contains a ten-membered carbocyclic ring
(chair–chair conformation) fused to a lactone ring (flattened
envelope-type conformation), and an epoxide ring, as
previously reported (Castañeda-Acosta & Fisher, 1993). The
title compound contains an E-exocyclic olefinic bond
C11 C13. The pyrimidine ring is twisted out of the plane of
the furan ring, making a dihedral angle of 29.43 (7). The
C11 C13—C16 bond angle of 127.89 (16) deviates from the
ideal value of 120, but other bond lengths and angles are
largely unremarkable. The four chiral carbon atoms in PTL
were determined using 1354 quotients (Parsons et al., 2013) as
follows: C4(R),C5(R),C6(S),C7(S) for the arbitrary atom-
numbering scheme used, and is consistent with previous
studies (Penthala et al., 2013).
3. Supramolecular features
There are no classical hydrogen bonds and no – inter-
actions. There are a few C—H  N and C—H  O short
contacts, but none that have the right geometry to be
considered as non-classical hydrogen bonds. Intermolecular
contacts thus appear to be limited to van der Waals inter-
actions.
4. Database survey
A search of the November 2014 release of the Cambridge
Structure Database (Groom & Allen, 2014) for the PTL
substructure gave 24 hits. Two of these (PARTEN: Quick &
Rogers, 1976; PARTEN01: Bartsch et al., 1983) give the
structure of PTL itself, with the remaining 22 being substituted
variants of PTL. Of these substituted parthenolides, only four
CSD entries: HORZOF (Penthala et al., 2014b), HUKLAB,
HUKLEF (Han et al., 2009) and QILGEZ (Penthala et al.,
2013), are substituted at the exocyclic double bond.
5. Synthesis and crystallization
Synthetic procedures: The title compound, containing the PTL
substructure, was synthesized by the previously reported
literature procedure (Han et al., 2009). In brief, parthenolide
(1 mmol), 5-bromopyrimidine (1.1 mmol), triethylamine
(3.0 mmol) and 5 mol% of palladium acetate were charged
into dimethylformamide (2 ml) at room temperature. The
reactants were stirred at 333–343 K for 24 h. After completion
of the reaction, the reaction mass was extracted into diethyl
ether (2  30 ml). The combined organic layers were dried
over anhydrous sodium sulfate, concentrated and purified by
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Figure 1
The molecular structure of the title compound with probability ellipsoids






Crystal system, space group Monoclinic, P21
Temperature (K) 90
a, b, c (Å) 10.3526 (2), 7.2612 (1), 11.9198 (2)
 () 108.1210 (6)
V (Å3) 851.60 (2)
Z 2
Radiation type Cu K
 (mm1) 0.70
Crystal size (mm) 0.25  0.13  0.10
Data collection
Diffractometer Bruker X8 Proteum
Absorption correction Multi-scan (SADABS; Bruker,
2006)
Tmin, Tmax 0.850, 0.942
No. of measured, independent and






R[F 2 > 2(F 2)], wR(F 2), S 0.027, 0.068, 1.05
No. of reflections 3020
No. of parameters 220
No. of restraints 1
H-atom treatment H-atom parameters constrained
	max, 	min (e Å
3) 0.15, 0.14
Absolute structure Flack x determined using 1354
quotients [(I+)(I)]/[(I+)+(I)]
(Parsons et al., 2013).
Absolute structure parameter 0.04 (3)
Computer programs: APEX2 and SAINT (Bruker, 2006), SHELXS97, SHELXTL and
XP in SHELXTL (Sheldrick, 2008), SHELXL2014 (Sheldrick, 2015) and CIFFIX
(Parkin, 2013).
column chromatography. The title compound was recrys-
tallized from a mixture of hexane and acetone (9:1), which
gave colourless needles upon slow evaporation of the solution
at room temperature over 24 h.
6. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 1. H atoms were found in difference
Fourier maps, but subsequently included in the refinement
using riding models, with constrained distances set to 0.95 Å
(Csp2H), 0.98 Å (RCH3), 0.99 Å (R2CH2) and 1.00 Å (R3CH).
Uiso(H) parameters were set to values of either 1.2Ueq or
1.5Ueq (RCH3 only) of the attached atom. The absolute
structure parameter [0.04 (3)] was determined directly from
the diffraction data using 1354 Parsons quotients (Parsons et
al., 2013), with the four chiral carbon atoms assigned to be
R,R,S,S for the arbitrarily numbered atoms C4, C5, C6, C7,
respectively.
Refinement progress was checked using PLATON (Spek,
2009) and by an R-tensor (Parkin, 2000).
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Computing details 
Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT (Bruker, 2006); data reduction: SAINT (Bruker, 2006); 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 
(Sheldrick, 2015); molecular graphics: XP in SHELXTL (Sheldrick, 2008); software used to prepare material for 







a = 10.3526 (2) Å
b = 7.2612 (1) Å
c = 11.9198 (2) Å
β = 108.1210 (6)°
V = 851.60 (2) Å3
Z = 2
F(000) = 348
Dx = 1.273 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 9908 reflections
θ = 4.5–68.2°
µ = 0.70 mm−1
T = 90 K
Solvent-rounded block, colourless
0.25 × 0.13 × 0.10 mm
Data collection 
Bruker X8 Proteum 
diffractometer
Radiation source: fine-focus rotating anode
Detector resolution: 5.6 pixels mm-1
φ and ω scans
Absorption correction: multi-scan 
(SADABS; Bruker, 2006)
Tmin = 0.850, Tmax = 0.942
11370 measured reflections
3020 independent reflections
3013 reflections with I > 2σ(I)
Rint = 0.032













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: difference Fourier map
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0326P)2 + 0.1773P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.15 e Å−3
Δρmin = −0.13 e Å−3
Extinction correction: SHELXL-2014, 
Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
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Extinction coefficient: 0.010 (2) Absolute structure: Flack x determined using 
1354 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et 
al., 2013).
Absolute structure parameter: −0.04 (3)
Special details 
Experimental. The crystal was mounted with polyisobutene oil on the tip of a fine glass fibre, which was fastened in a 
copper mounting pin with electrical solder. It was placed directly into the cold gas stream of a liquid nitrogen based 
cryostat, according to published methods. 
Diffraction data were collected with the crystal at 90 K, which is standard practice in this laboratory for the majority of 
flash-cooled crystals.
The crystals were large, and could not be cut to size without inducing damage by crushing, leading to shattered, frayed 
ends. These damaged parts could easily be dissolved away, however, to give solvent-rounded undamaged pieces of 
optimal size for data collection.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement progress was checked using PLATON (Spek, 2009) and by an R-tensor (Parkin, 2000). The final 
model was further checked with the IUCr utility checkCIF.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
O1 0.59428 (12) 0.24072 (19) 0.48957 (10) 0.0228 (3)
O2 0.30633 (12) 0.25486 (17) 0.43887 (10) 0.0195 (3)
O3 0.12397 (13) 0.29255 (19) 0.49855 (11) 0.0266 (3)
C1 0.57679 (17) 0.5285 (2) 0.19945 (14) 0.0185 (4)
H1A 0.5833 0.6439 0.2384 0.022*
C2 0.70386 (17) 0.4134 (3) 0.23289 (16) 0.0208 (4)
H2A 0.7809 0.4881 0.2257 0.025*
H2B 0.6915 0.3076 0.1781 0.025*
C3 0.73676 (17) 0.3417 (3) 0.36116 (15) 0.0202 (4)
H3A 0.8146 0.2554 0.3792 0.024*
H3B 0.7615 0.4460 0.4173 0.024*
C4 0.61322 (17) 0.2447 (2) 0.37345 (14) 0.0178 (4)
C5 0.51035 (16) 0.3615 (2) 0.40010 (13) 0.0165 (3)
H5A 0.5353 0.4948 0.4118 0.020*
C6 0.35977 (16) 0.3252 (2) 0.34753 (14) 0.0159 (3)
H6A 0.3445 0.2321 0.2829 0.019*
C7 0.27894 (16) 0.5036 (2) 0.29783 (13) 0.0149 (3)
H7A 0.3396 0.6113 0.3292 0.018*
C8 0.22800 (16) 0.5184 (3) 0.16174 (14) 0.0176 (4)
H8A 0.1434 0.5923 0.1376 0.021*
H8B 0.2058 0.3936 0.1278 0.021*
C9 0.33322 (17) 0.6078 (3) 0.11062 (14) 0.0185 (4)
H9A 0.2884 0.6358 0.0261 0.022*
H9B 0.3638 0.7258 0.1519 0.022*
C10 0.45591 (17) 0.4887 (2) 0.12176 (14) 0.0179 (4)
C11 0.16862 (16) 0.5027 (2) 0.35605 (14) 0.0159 (3)
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C12 0.19100 (17) 0.3425 (3) 0.43718 (14) 0.0184 (4)
C13 0.06867 (17) 0.6212 (3) 0.35248 (14) 0.0179 (4)
H13A 0.0096 0.5872 0.3961 0.021*
C14 0.42876 (19) 0.3267 (3) 0.03864 (16) 0.0269 (4)
H14A 0.5140 0.2609 0.0473 0.040*
H14B 0.3908 0.3705 −0.0428 0.040*
H14C 0.3639 0.2434 0.0573 0.040*
C15 0.57578 (18) 0.0643 (2) 0.30934 (18) 0.0239 (4)
H15A 0.5012 0.0072 0.3311 0.036*
H15B 0.6548 −0.0179 0.3312 0.036*
H15C 0.5470 0.0861 0.2240 0.036*
C16 0.03901 (16) 0.7977 (2) 0.28928 (14) 0.0180 (4)
C17 0.13568 (18) 0.9097 (3) 0.26601 (18) 0.0244 (4)
H17A 0.2281 0.8719 0.2933 0.029*
N18 0.10538 (16) 1.0688 (2) 0.20684 (16) 0.0293 (4)
C19 −0.02533 (19) 1.1156 (3) 0.17269 (17) 0.0252 (4)
H19A −0.0485 1.2265 0.1287 0.030*
N20 −0.12697 (15) 1.0248 (2) 0.19312 (14) 0.0256 (4)
C21 −0.09291 (18) 0.8673 (3) 0.25279 (15) 0.0219 (4)
H21A −0.1621 0.7994 0.2713 0.026*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0188 (6) 0.0306 (7) 0.0176 (6) 0.0061 (5) 0.0035 (5) 0.0092 (5)
O2 0.0187 (6) 0.0200 (6) 0.0221 (6) 0.0038 (5) 0.0098 (5) 0.0064 (5)
O3 0.0242 (6) 0.0305 (8) 0.0303 (7) 0.0031 (6) 0.0162 (5) 0.0097 (6)
C1 0.0218 (8) 0.0163 (8) 0.0197 (8) −0.0006 (7) 0.0100 (7) 0.0024 (7)
C2 0.0184 (8) 0.0208 (9) 0.0254 (9) −0.0018 (7) 0.0101 (7) −0.0001 (7)
C3 0.0157 (8) 0.0216 (9) 0.0228 (8) 0.0016 (7) 0.0053 (6) −0.0004 (7)
C4 0.0163 (8) 0.0184 (8) 0.0174 (8) 0.0036 (7) 0.0031 (6) 0.0040 (7)
C5 0.0175 (8) 0.0173 (8) 0.0141 (7) 0.0020 (7) 0.0043 (6) 0.0031 (6)
C6 0.0173 (8) 0.0162 (8) 0.0154 (7) 0.0002 (6) 0.0068 (6) 0.0012 (6)
C7 0.0155 (7) 0.0147 (8) 0.0142 (7) −0.0011 (6) 0.0041 (6) −0.0008 (6)
C8 0.0172 (8) 0.0201 (8) 0.0143 (8) 0.0005 (7) 0.0034 (6) 0.0003 (7)
C9 0.0209 (8) 0.0195 (8) 0.0147 (7) 0.0018 (7) 0.0051 (6) 0.0044 (7)
C10 0.0221 (8) 0.0190 (9) 0.0150 (7) 0.0003 (7) 0.0092 (7) 0.0026 (7)
C11 0.0153 (7) 0.0170 (8) 0.0143 (7) −0.0021 (7) 0.0031 (6) −0.0010 (7)
C12 0.0166 (8) 0.0206 (9) 0.0187 (8) 0.0004 (7) 0.0065 (6) 0.0014 (7)
C13 0.0144 (8) 0.0213 (9) 0.0175 (8) −0.0011 (7) 0.0044 (6) −0.0018 (7)
C14 0.0258 (9) 0.0321 (11) 0.0219 (8) 0.0041 (8) 0.0061 (7) −0.0061 (8)
C15 0.0206 (8) 0.0177 (9) 0.0346 (10) 0.0023 (7) 0.0105 (8) 0.0005 (7)
C16 0.0175 (8) 0.0190 (9) 0.0161 (7) 0.0009 (7) 0.0032 (6) −0.0044 (7)
C17 0.0156 (8) 0.0189 (9) 0.0350 (10) 0.0005 (7) 0.0024 (8) 0.0019 (8)
N18 0.0209 (8) 0.0216 (9) 0.0409 (10) −0.0014 (6) 0.0030 (7) 0.0062 (7)
C19 0.0240 (9) 0.0183 (9) 0.0288 (9) 0.0021 (8) 0.0016 (7) 0.0019 (8)
N20 0.0206 (8) 0.0232 (8) 0.0304 (8) 0.0042 (6) 0.0043 (6) 0.0003 (7)
C21 0.0194 (8) 0.0219 (9) 0.0253 (9) 0.0026 (7) 0.0084 (7) −0.0024 (7)
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Geometric parameters (Å, º) 
O1—C5 1.444 (2) C8—H8B 0.9900
O1—C4 1.457 (2) C9—C10 1.508 (2)
O2—C12 1.348 (2) C9—H9A 0.9900
O2—C6 1.4585 (19) C9—H9B 0.9900
O3—C12 1.210 (2) C10—C14 1.507 (3)
C1—C10 1.337 (2) C11—C13 1.336 (2)
C1—C2 1.504 (2) C11—C12 1.484 (2)
C1—H1A 0.9500 C13—C16 1.470 (2)
C2—C3 1.549 (2) C13—H13A 0.9500
C2—H2A 0.9900 C14—H14A 0.9800
C2—H2B 0.9900 C14—H14B 0.9800
C3—C4 1.507 (2) C14—H14C 0.9800
C3—H3A 0.9900 C15—H15A 0.9800
C3—H3B 0.9900 C15—H15B 0.9800
C4—C5 1.471 (2) C15—H15C 0.9800
C4—C15 1.505 (3) C16—C17 1.383 (3)
C5—C6 1.511 (2) C16—C21 1.393 (2)
C5—H5A 1.0000 C17—N18 1.339 (2)
C6—C7 1.556 (2) C17—H17A 0.9500
C6—H6A 1.0000 N18—C19 1.330 (2)
C7—C11 1.510 (2) C19—N20 1.327 (3)
C7—C8 1.546 (2) C19—H19A 0.9500
C7—H7A 1.0000 N20—C21 1.335 (3)
C8—C9 1.547 (2) C21—H21A 0.9500
C8—H8A 0.9900
C5—O1—C4 60.94 (10) H8A—C8—H8B 107.8
C12—O2—C6 111.31 (12) C10—C9—C8 113.70 (14)
C10—C1—C2 128.05 (17) C10—C9—H9A 108.8
C10—C1—H1A 116.0 C8—C9—H9A 108.8
C2—C1—H1A 116.0 C10—C9—H9B 108.8
C1—C2—C3 110.73 (14) C8—C9—H9B 108.8
C1—C2—H2A 109.5 H9A—C9—H9B 107.7
C3—C2—H2A 109.5 C1—C10—C14 124.58 (16)
C1—C2—H2B 109.5 C1—C10—C9 121.22 (16)
C3—C2—H2B 109.5 C14—C10—C9 114.20 (15)
H2A—C2—H2B 108.1 C13—C11—C12 119.20 (15)
C4—C3—C2 108.68 (14) C13—C11—C7 132.19 (16)
C4—C3—H3A 110.0 C12—C11—C7 108.42 (13)
C2—C3—H3A 110.0 O3—C12—O2 121.43 (16)
C4—C3—H3B 110.0 O3—C12—C11 128.78 (16)
C2—C3—H3B 110.0 O2—C12—C11 109.75 (13)
H3A—C3—H3B 108.3 C11—C13—C16 127.89 (16)
O1—C4—C5 59.08 (10) C11—C13—H13A 116.1
O1—C4—C15 112.05 (15) C16—C13—H13A 116.1
C5—C4—C15 121.46 (15) C10—C14—H14A 109.5
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O1—C4—C3 118.08 (14) C10—C14—H14B 109.5
C5—C4—C3 116.40 (15) H14A—C14—H14B 109.5
C15—C4—C3 116.73 (15) C10—C14—H14C 109.5
O1—C5—C4 59.97 (10) H14A—C14—H14C 109.5
O1—C5—C6 120.41 (14) H14B—C14—H14C 109.5
C4—C5—C6 122.16 (14) C4—C15—H15A 109.5
O1—C5—H5A 114.5 C4—C15—H15B 109.5
C4—C5—H5A 114.5 H15A—C15—H15B 109.5
C6—C5—H5A 114.5 C4—C15—H15C 109.5
O2—C6—C5 109.48 (12) H15A—C15—H15C 109.5
O2—C6—C7 106.97 (12) H15B—C15—H15C 109.5
C5—C6—C7 112.07 (13) C17—C16—C21 115.11 (16)
O2—C6—H6A 109.4 C17—C16—C13 124.52 (15)
C5—C6—H6A 109.4 C21—C16—C13 120.31 (15)
C7—C6—H6A 109.4 N18—C17—C16 123.19 (16)
C11—C7—C8 115.01 (13) N18—C17—H17A 118.4
C11—C7—C6 102.45 (13) C16—C17—H17A 118.4
C8—C7—C6 115.15 (13) C19—N18—C17 115.52 (17)
C11—C7—H7A 107.9 N20—C19—N18 127.34 (18)
C8—C7—H7A 107.9 N20—C19—H19A 116.3
C6—C7—H7A 107.9 N18—C19—H19A 116.3
C7—C8—C9 112.99 (13) C19—N20—C21 115.48 (15)
C7—C8—H8A 109.0 N20—C21—C16 123.23 (17)
C9—C8—H8A 109.0 N20—C21—H21A 118.4
C7—C8—H8B 109.0 C16—C21—H21A 118.4
C9—C8—H8B 109.0
C10—C1—C2—C3 −110.99 (19) C2—C1—C10—C14 −8.9 (3)
C1—C2—C3—C4 53.54 (19) C2—C1—C10—C9 171.47 (16)
C5—O1—C4—C15 −114.44 (16) C8—C9—C10—C1 −107.23 (18)
C5—O1—C4—C3 105.54 (17) C8—C9—C10—C14 73.07 (19)
C2—C3—C4—O1 −152.28 (15) C8—C7—C11—C13 −56.5 (2)
C2—C3—C4—C5 −84.95 (18) C6—C7—C11—C13 177.78 (17)
C2—C3—C4—C15 69.54 (18) C8—C7—C11—C12 128.73 (15)
C4—O1—C5—C6 111.94 (17) C6—C7—C11—C12 3.06 (16)
C15—C4—C5—O1 98.43 (17) C6—O2—C12—O3 172.90 (16)
C3—C4—C5—O1 −108.37 (16) C6—O2—C12—C11 −9.33 (18)
O1—C4—C5—C6 −109.10 (17) C13—C11—C12—O3 5.6 (3)
C15—C4—C5—C6 −10.7 (2) C7—C11—C12—O3 −178.86 (18)
C3—C4—C5—C6 142.53 (15) C13—C11—C12—O2 −171.94 (15)
C12—O2—C6—C5 132.85 (14) C7—C11—C12—O2 3.59 (18)
C12—O2—C6—C7 11.21 (17) C12—C11—C13—C16 172.57 (15)
O1—C5—C6—O2 36.7 (2) C7—C11—C13—C16 −1.7 (3)
C4—C5—C6—O2 108.24 (17) C11—C13—C16—C17 −29.8 (3)
O1—C5—C6—C7 155.20 (14) C11—C13—C16—C21 153.17 (17)
C4—C5—C6—C7 −133.25 (15) C21—C16—C17—N18 −3.7 (3)
O2—C6—C7—C11 −8.19 (16) C13—C16—C17—N18 179.10 (17)
C5—C6—C7—C11 −128.18 (14) C16—C17—N18—C19 1.1 (3)
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O2—C6—C7—C8 −133.78 (14) C17—N18—C19—N20 1.7 (3)
C5—C6—C7—C8 106.23 (15) N18—C19—N20—C21 −1.4 (3)
C11—C7—C8—C9 153.12 (15) C19—N20—C21—C16 −1.7 (3)
C6—C7—C8—C9 −88.08 (18) C17—C16—C21—N20 4.0 (2)
C7—C8—C9—C10 69.71 (19) C13—C16—C21—N20 −178.66 (16)
